A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528 (Q34322552)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528 |
scientific article |
Statements
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528 (English)
Grace K Dy
Alex A Adjei
Julian R Molina
Rafat H Ansari
Araba A Adjei
Sumithra J Mandrekar
Jeffrey P Meyers
Helen J Ross
Alan P Lyss
Philip J Stella
1 January 2013
1 reference
1 reference